10-Q: Hercules Capital Reports First Quarter 2024 Results, Portfolio Shows Strong Growth
Quarterly Report
Hercules Capital's first quarter 2024 results show a significant increase in investment income and a growing portfolio, despite some unrealized depreciation.
Summary
- Hercules Capital reported a net increase in net assets resulting from operations of $91.0 million for the first quarter of 2024.
- The company's total investment income reached $121.6 million, up from $105.1 million in the same period last year.
- Net investment income was $79.2 million, compared to $65.5 million in the first quarter of 2023.
- The company experienced a net realized gain of $8.2 million and a net change in unrealized appreciation of $3.6 million.
- The company's total assets increased to $3.7 billion, up from $3.4 billion at the end of 2023.
- The company's total debt outstanding was $1.8 billion as of March 31, 2024.
- The company's net asset value per share increased to $11.63 from $11.43 at the end of 2023.
Sentiment
Score: 7
Explanation: The document presents a generally positive outlook with strong growth in investment income and net asset value, but also acknowledges some risks and unrealized depreciation. The company's performance is solid, but the macroeconomic environment and potential for credit losses temper the overall sentiment.
Positives
- The company's net investment income increased by approximately 21% year-over-year.
- The company's total assets increased by approximately 8% since the end of 2023.
- The company's net asset value per share increased by approximately 2% since the end of 2023.
- The company has a significant amount of unfunded commitments, which represents potential for future growth.
Negatives
- The company experienced a net change in unrealized depreciation of $3.6 million, indicating some portfolio investments decreased in value.
- The company's operating expenses increased to $42.4 million, up from $39.6 million in the same period last year.
- The company's cash and cash equivalents decreased to $50.2 million from $98.9 million at the end of 2023.
Risks
- The company's portfolio is subject to market risks, including changes in interest rates and credit quality.
- The company's portfolio is concentrated in technology, life sciences, and sustainable and renewable technology industries, which may be subject to volatility.
- The company's portfolio companies are primarily privately held, which may make valuation more difficult.
- The company's portfolio companies may be impacted by macroeconomic events, including inflation, interest rate volatility, and potential recession.
- The company's debt investments are subject to credit risk, and some may be placed on non-accrual status.
Future Outlook
The company intends to continue to operate in order to generate cash flows from operations, including income earned from investments in our portfolio companies. Our primary use of funds will be investments in portfolio companies and cash distributions to holders of our common stock.
Management Comments
- Management believes they and their portfolio are well positioned to manage the current environment.
- Management will continue to monitor macroeconomic market developments and their related impact to their business.
Industry Context
The company operates in the specialty finance sector, focusing on high-growth, innovative companies in technology, life sciences, and sustainable and renewable technology industries. This sector is characterized by high margins, high growth rates, consolidation and product and market extension opportunities. The company's performance is influenced by the overall health of the venture capital market and the success of its portfolio companies.
Comparison to Industry Standards
- Hercules Capital's core yield on debt investments was 14.0% for the three months ended March 31, 2024, which is within the range of other BDCs focused on venture debt.
- The company's net asset value per share increased to $11.63, which is a positive indicator compared to some BDCs that have experienced NAV declines.
- The company's total return of 13.6% for the three months ended March 31, 2024, is a strong performance compared to the average BDC total return.
- The company's portfolio is concentrated in technology and life sciences, which is a common strategy for BDCs focused on venture debt, but may be more volatile than BDCs with more diversified portfolios.
- The company's use of floating rate debt investments is a common strategy for BDCs to benefit from rising interest rates, but may also expose them to interest rate risk.
Related Party Transactions
- The Adviser Subsidiary has entered into investment management agreements with its privately offered Adviser Funds, and it receives management fees based on the assets under management of the Adviser Funds.
- The Company has a shared services agreement with the Adviser Subsidiary, through which the Adviser Subsidiary has access to the Company's human capital resources and other resources and infrastructure.
- The Company may from time-to-time make investments alongside the Adviser Funds or assign a portion of investments to the Adviser Funds in accordance with the Companys allocation policy.
Stakeholder Impact
- Shareholders benefit from the increase in net asset value per share and the continued payment of dividends.
- Employees benefit from the company's continued growth and profitability.
- Portfolio companies benefit from the company's continued investment and support.
- Creditors benefit from the company's strong financial position and ability to repay its obligations.
Next Steps
- The company will continue to monitor macroeconomic market developments and their related impact to their business.
- The company will continue to evaluate its overall liquidity position and take proactive steps to maintain the appropriate liquidity position based upon the current circumstances.
Key Dates
| Date | Description |
|---|---|
| 2018-09-24 | Date of issuance of the 2033 Notes. |
| 2020-02-05 | Date of issuance of the February 2025 Notes. |
| 2020-06-03 | Date of issuance of the June 2025 Notes. |
| 2020-10-27 | Date Hercules Capital IV, L.P. received its license to operate as a Small Business Investment Company (SBIC). |
| 2020-11-04 | Date of issuance of the March 2026 A Notes. |
| 2021-03-04 | Date of issuance of the March 2026 B Notes. |
| 2021-09-16 | Date of issuance of the September 2026 Notes. |
| 2022-01-20 | Date of issuance of the January 2027 Notes. |
| 2022-06-22 | Date of issuance of the 2031 Asset-Backed Notes. |
| 2023-05-05 | Date of the 2023 Equity Distribution Agreement. |
| 2024-03-06 | Date of declaration of the base and supplemental cash distributions. |
| 2024-03-31 | End of the reporting period. |
| 2024-04-25 | Date of declaration of the supplemental cash distribution. |
| 2024-05-21 | Date of payment of the base and supplemental cash distributions. |
Keywords
Business Development Company, BDC, Venture Capital, Debt Financing, Technology, Life Sciences, Sustainable Technology, Renewable Technology, Structured Debt, Private Equity, Investment Income, Net Asset Value, Unfunded Commitments, Credit Risk, Interest Rate Risk
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.